Merck & Co. Inc.'s recovery effort from a recent cyberattack now includes another high-profile item on the to-do list: responding to a congressional inquiry on the damage to its manufacturing operations.
The House Energy and Commerce Committee has asked Merck for a briefing by Oct. 4 on the malware infection, which disrupted the pharmaceutical company's manufacturing capabilities.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?